Kavita Y Sarin Selected Research

Wells syndrome

9/2012

Treatment of recalcitrant eosinophilic cellulitis with adalimumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kavita Y Sarin Research Topics

Disease

20	Neoplasms (Cancer) 04/2024 - 08/2005
8	Basal Cell Carcinoma (Rodent Ulcer) 07/2021 - 03/2015
6	Melanoma (Melanoma, Malignant) 03/2023 - 01/2016
4	Dermatomyositis (Dermatopolymyositis) 10/2023 - 02/2014
3	Neurofibroma 05/2024 - 01/2021
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2023 - 01/2019
3	Nevus (Nevi) 01/2019 - 09/2013
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 05/2024 - 01/2021
2	Disease Progression 01/2023 - 01/2018
2	Basal Cell Neoplasms (Basal Cell Cancer) 01/2018 - 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023
1	Skin Diseases (Skin Disease) 10/2023
1	Neoplasm Metastasis (Metastasis) 03/2023
1	Skin Neoplasms (Skin Cancer) 01/2023
1	COVID-19 09/2022
1	Blister (Bulla) 01/2022
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 06/2019
1	Hypohidrosis 06/2019
1	Leukemia 01/2018
1	Glioma (Gliomas) 01/2018
1	Hidradenitis 01/2018
1	Basosquamous Carcinoma 01/2017
1	Inflammation (Inflammations) 01/2017
1	Wells syndrome 09/2012

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 03/2023 - 08/2005
4	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2017
4	HhAntag691IBA 01/2018 - 03/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2024 - 10/2023
2	remetinostatIBA 01/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 11/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2017
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2017 - 08/2005
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2024
1	Hematoxylin (Haematoxylon)IBA 04/2024
1	BNT162 VaccineIBA 03/2024
1	AntibodiesIBA 10/2023
1	InterferonsIBA 10/2023
1	Interferon Type IIBA 10/2023
1	Immunoglobulin IsotypesIBA 10/2023
1	Immune Checkpoint InhibitorsIBA 03/2023
1	Immune Checkpoint ProteinsIBA 03/2023
1	diphenylcyclopropenoneIBA 03/2023
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2022
1	bazlitoranIBA 04/2021
1	Toll-Like Receptor 7IBA 04/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	Fibronectins (Fibronectin)IBA 11/2018
1	IntegrinsIBA 11/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2018
1	AsbestosIBA 10/2018
1	Azathioprine (Imuran)FDA LinkGeneric 01/2018
1	ZincIBA 01/2018
1	ForminsIBA 01/2018
1	Atorvastatin (Lipitor)FDA Link 01/2018
1	Histone Deacetylase 1IBA 11/2017
1	Staphylococcal Protein A (Protein A)IBA 06/2017
1	Actins (F Actin)IBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017
1	sonidegibIBA 03/2016
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2016
1	Adrenergic alpha-Agonists (Adrenergic alpha-Agonist)IBA 01/2016
1	Capecitabine (Xeloda)FDA Link 02/2014
1	Adalimumab (Humira)FDA Link 09/2012

Therapy/Procedure

11	Therapeutics 12/2023 - 03/2015
2	Immunotherapy 03/2023 - 01/2023
2	Drug Therapy (Chemotherapy) 06/2019 - 09/2013
1	Chemoprevention 10/2023
1	Immunomodulation 01/2023
1	Ambulatory Care (Outpatient Care) 09/2022